chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This non-serious initial spontaneous case, was received on 19-Oct-2017 from other non-health professional and concerns a 65-year-old, adult, male patient. On an unspecified (reported as mid-December), the patient was administered with influenza virus vaccine polyvalent (dose, batch number, route of administration, anatomical location, expiry date, trade name and manufacture: not reported). On unspecified date, (reported as early January) after the administration of vaccine, the patient was sick and experienced chills, fatigue, fever and he felt bad for a few days. It was reported that, the patient self-diagnosed the flu and he was not 100 percent sure that it was flu. The outcome of the event was not reported.
Having sleeping problem; sleeplessness; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Having sleeping problem ) and INSOMNIA (sleeplessness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SLEEP DISORDER (Having sleeping problem ) and INSOMNIA (sleeplessness). At the time of the report, SLEEP DISORDER (Having sleeping problem ) and INSOMNIA (sleeplessness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
This spontaneous report was received from a medical assistant via agency referring to a 13 year old female patient. The patient did not have any medical history, concurrent conditions and past drug history. On 14-MAR-2016, the patient was vaccinated with an adult dose of VAQTA (1 ml, once, lot # L017757, expiry date: 08-APR-2018, route unknown). No concomitant therapies were reported. There was no relevant lab work done. Additional information has been requested. It has been determined, that the initial version of case # US-009507513-1603USA007143 was sent with wrong aware date. The report should have been submitted with aware date of 14-MAR-2016 instead of 15-MAR-2016. Therefore, case # US-009507513-1603USA007143 is being deleted from our files on hepatitis a vaccine, inactivated and a new case # US-009507513-1604USA002092 is created to replace MARRS # US-009507513-1603USA007143.
child received thre vaccines for k-pe, after leaving office, started vomiting in lobby downstairs on the way out.  mom states child c/p throat feeling funny.  after returning to office, temp taken 97.7, no sweling or reddness of throat noted, c/o pain of throat on palpation, chest clear no difficulty breathing noted continued to vomit while in office, arouses easily, discussed with doctor and was directed to er
Hurting all over, neck, arms, shoulder, legs; Feels tired, sluggish; Hurting all over, neck, arms, shoulder, legs; Hurting all over, neck, arms, shoulder, legs; Hurting all over, neck, arms, shoulder, legs; Feels tired, sluggish; Headache since she woke up this morning; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache since she woke up this morning), ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the first episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs) and the second episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Atrial fibrillation.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Headache since she woke up this morning). On an unknown date, the patient experienced ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the first episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), the second episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), NECK PAIN (Hurting all over, neck, arms, shoulder, legs) and SLUGGISHNESS (Feels tired, sluggish). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (Headache since she woke up this morning), ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the last episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), NECK PAIN (Hurting all over, neck, arms, shoulder, legs) and SLUGGISHNESS (Feels tired, sluggish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.
CELLULITIS OF RIGHT UPPER EXTREMITY, FROM SITE OF INJECTION DISTALLY BEYOND BEND OF THE ELBOW.  PRESENTED WITH PAIN, LOW GRADE FEVER AND REDNESS TIMES TWO DAYS.
Exactly two weeks after my first dose I got really dizzy and started spinning. It?s been one week and I?m still really dizzy. I also had a migraine for 5 days. I?m still having issues withy neck.
1545 immediately after giving DEPO and Flu vaccine to patient, Mom brought patient back for allergic reaction. Hives noted, one on her R hand, L foot, and then one under her eye. Denies SOB, difficulty breathing, fast heartbeat, dizziness, weakness or swelling of the face or throat. Mom immediately gave her daughter BENADRYL. Dr aware, and at bedside. Will continue to monitor patient longer. 1615 patient discharged home, ok per Dr. Note pt had fever to 102 the next day.
Pt received Vaccine and then on 10/30 had developed syncope from GI bleed. received transfusion of 2 units of PRBC.  Colonoscopy 10/31/2021 showed grade 3 prep right colon grade 2 prep left and transverse.  1 sigmoid polyp was removed, he was noted to have large internal hemorrhoids with 1 column of hemorrhoids with stigmata of recent bleeding.  1 hemorrhoid had evidence of prior banding in 1 had stigmata of recent bleeding.  No active bleeding up to the TI. PATH of polyp was fragments of tubular adenoma He was hospitalized again for anemia received transfusion  again and was rehospitialized for bleeding .
Meningococcal was mixed with sterile diluent instead of Liqiud Conjugate Component - contacted patient and has no side effects
1 Hr. Post Vaccine Symptoms: Nausea, Fatigue 11 Hrs. Post Vaccine Symptoms: (7 of10) Sternum-Chest pain, (7 of 10)Lower Back-Kidney Pain, Fever 101.8, (9/10)Severe Headache, Brain Fog(9/10)Nausea, (9/10)Dizzy, ((8/10)Burning sensation in legs, Weakness & Full body joint pain, Fatigue.  36 Hrs. Post Vaccine Symptoms:  Dizzy, Fatigue, Nausea, Faint feeling. 46 Hrs. Post Vaccine Symptoms:: Fatigue
Pt with generalized seizure within 24 hours after immunizations 4/4/08-records received for DOS 2/10/08-DC DX: Seizures. Tonic clonic activity. Right arm twitching.  Follow-up: Chronic recurrent seizures. Pt has not been seen in office since immunization. Pt was seen by neurology and started on antiseizure meds.
Regional hypersensitivity reaction in (R) arm with rubor, calor, tumor and dolor all of which are receding since initial reaction about 12 h. after injection.
This is a spontaneous report from a contactable physician through a Pfizer sales representative. This physician reported similar events for 3 patients. This is the third of three reports. A patient of unknown age, gender and race received PREVNAR 13 on an unknown date, at single dose, for immunization. Relevant medical history and concomitant medication were unknown. On an unknown date the patient was sick and started vomiting about 3 hours after vaccination. The patient was better within 24 hours and was recovering from the events at the time of report.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2016542398 same reporter/different patient, same product, similar events;US-PFIZER INC-2016542415 same reporter/different patient, same product, similar events.
The patient, 33 y/o male, felt sudden dizziness and had a drop in blood pressure about 5 hours after receiving his first Moderna vaccine.  The next day, on 03/25/2021, the patient had a high fever throughout the day with the temperature reaching 104.8 C in the afternoon. Note - The patient was ill with Covid in December 2020
NO ADVERSE EVENT; Doses were administered after the 30 day BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.  In June 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In June 2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (NO ADVERSE EVENT). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (NO ADVERSE EVENT) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD).    Concomitant product use was not provided by the reporter.  Doses were administered after the 30 day BUD between 08-Jun-2023 to 15-Jun-2023.  Seven doses were administered. No doses were administered during that weekend.   No reported symptoms or side effects.  Treatment information was not provided.  This case contains information for the 6th patient out of 7 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-729901.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-729901:Master case
lymphedema - in my opposite arm - left arm; sweats; chills; headache; swelling; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (lymphedema - in my opposite arm - left arm), HYPERHIDROSIS (sweats), CHILLS (chills), HEADACHE (headache) and SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHOEDEMA (lymphedema - in my opposite arm - left arm), HYPERHIDROSIS (sweats), CHILLS (chills), HEADACHE (headache) and SWELLING (swelling). At the time of the report, LYMPHOEDEMA (lymphedema - in my opposite arm - left arm), HYPERHIDROSIS (sweats), CHILLS (chills), HEADACHE (headache) and SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-058199 (Patient Link).   Reporter did not allow further contact
Fever to 104 two hours after vaccinations, lasting for 2-3 days.
High feber for 24 hrs - peaking at 103F. Chills, cramps, fatigue. Recurred 7 days later on 4/11/2021
Vaccines given 8/30/07.  awoke 8/31/07 with "raspy, phlegm sounding" cough, no fever.  9/7/07 broke out with "red dot, itchy rash" on back.  Over course of three days rash spread to neck, chest, abdomen, both arms, and few spots on legs.  9/10/07 Dr. appt. ordered blood test, RX for zithromax and atarax. 9/14/07 rash still present, but "drying"up per mother. Mother states on 9/14/2007 she broke out in same rash with similar pattern.
My daughter is experiencing a headache  centralized to the lower right of back of head by her neck. She woke up to tonight to go pee because she had the sensation to go pee, but she is unable to go pee. We had been up for a couple hours complaining that she needs to pee but cannot.
pt recvd vax & devel flu-like symptoms consisting of watery eyes & runny nose, sneezing, fever, severe nausea, chills body aches & coughing; pt was dx w/ bronchitis & felt sick;
Bleeding after injection. Swollen under skin, injection appeared to have been given subcutaneously rather than intramuscularly as intended. Injection site reactions started immediately after the injection. Treatment for reaction was given in the form of an ice pack. Patient remained at the pharmacy and was icing the injection site for at least five minutes and most likely continued at home.
This spontaneous report was received from a Licensed Practice Nurse refers to 3 to 5 patients of unknown age and gender. No medical history was reported. On an unknown date, the patients were vaccinated with a dose of 0.5 ml PNEUMOVAX 23 (lot # h015780, expiry: 11-JUN-2014) intramuscularly. No concomitant medications were reported. On an unknown date, the patients experienced swelling and redness at injection (reported as similar reactions to the related cases). The outcome of swelling of redness at injection site was unknown. The relatedness of the events with PNEUMOVAX 23 was unknown. The nurse called because she is requesting to have a lot check done for PNEUMOVAX 23. This is 1 of 3 reports from the same source. Additional information has been requested.
Patient observed for 30 minutes post vaccination with no issues. Called following day to report feelings of feet/leg burning/itching and hives on upper back that started around 11pm on day of vaccination. She contacted local 24 hr pharmacy at 1am and was told to take 2 Benadryl and call cdc to report. Next morning reported residual body itchiness and facial area numbness/decreased feeling for which she redosed 2 more Benadryl. Later that afternoon she took another 2 Benadryl and reported to program and contacted cdc. Morning of 3/2 patient states itchiness is gone but facial numbness still present. I reported to her pcp and she will reach out to him as well to determine if 2nd dose should be given on 3/28.
This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the right arm on 08May2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 17Apr2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 12Jul2021 at 14:00, the patient experienced cold feet and legs, cold arms and shooting pain in arms for over a month. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events Cold feet and legs/ cold arms and shooting pain in arms were resolved with sequelae on an unknown date in 2021.
Very bad pain in my left shoulder, elbow and arm. I could not lift my arm very far for a week after receiving the Moderna Covid-19 Vaccine. It has been a three weeks now and the pain is not as bad but I still have pain in my left arm and elbow plus my arm feels weaker than it was before receiving the shot.
Difficulty breathing - resolved by 3L O2 and Albuterol breathing treatment vital signs stable, O2 Sat 94% on room air after 1 hour.
myocarditis and associated ailments, encephalopathy due to [poisoning and endless for 2 months due to poisoning by spikevax
Started with cold-like symptoms; I was sneezing and had cold symptoms. I couldn't sleep and developed a fever on Friday morning, 100.1. I took cold medicine; took extra vit C pills, broth and ate tangerines and it was gone in an hour I got a COVID test, positive result, didn't get the result confirmation until I had lost sense of smell, night of the 10th. Didn't lose taste and I got my sense of smell back until a few days later. Had sneezing and congestion of sinuses. By Wednesday, I was coughing. I was using my CPAP sleeping on my stomach. It was weird in color, what was coming up from the coughing. I tried to get an x-ray at urgent care. I went to a local ER, got an x-ray which was fine. Given my history and my size (I'm over 300 lbs), they advised me to do a monoclonal antibody treatment as well. Got that treatment on the 15th. By the 18th, all that stuff (symptoms) was gone. I had crazy fatigue and exhaustion for the next week, that was the hard part. Since the 25th, I have been fine since then. It lasted 2-3 weeks.
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On an unknown dates, an unspecified number of patients were vaccinated with unknown number of doses of M-M-R II, (strength, dose, route, anatomical location, lot number and expiration date were not reported), which were improperly stored. No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of three reports received from the same reporter. Additional information has been requested.
Child received vaccines & fluoride dental varnish. Left clinic & returned with facial urticaria & wheezing.
I have had a rebound in testing positive (no symptoms), 6 days after completing paxlovid. In the time between completing my course and testing positive again, I received 3 negative at home rapids; I have had a rebound in testing positive (no symptoms), 6 days after completing paxlovid. In the time between completing my course and testing positive again, I received 3 negative at home rapids; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Nov2021 at 16:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 28 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "I have had a rebound in testing positive (no symptoms), 6 days after completing paxlovid. In the time between completing my course and testing positive again, I received 3 negative at home rapids".  The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (Apr2022) Positive, notes: In the time between completing my course and testing positive again, I received 3 negative at home rapids and a negative PCR test; (Apr2022) Negative, notes: In the time between completing my course and testing positive again, I received 3 negative at home rapids and a negative PCR test; (01May2022) Positive; (Apr2022) Negative, notes: In the time between completing my course and testing positive again, I received 3 negative at home rapids and a negative PCR test. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid on 20Apr2022 to 25Apr2022. No other medication in 2 weeks.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The arm that shot was given is red and very rash  looking.  Runs down my arm to just above the elbow.  Itchy.  And arm is still sore and rash is still there 4 days later.
The pt experienced unresolved pain at injection site with 2 small pea sized swelling increasing in size to 30 mm, red, indurated, warm, remains sensitive to the touch. The pt also experienced arthralgia, dizziness, malaise.
onset sz (minor, but persistent not assoc w/fever-started on Phenobarb for control
Flushed; Hot feeling; Numb back of tongue or throat; Numb back of tongue or throat; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL0142), intramuscular in left arm, on 08Jan2021 at 12:00, at a single dose, for COVID-19 immunization. The patient's medical history included Bell's palsy from 2017. The patient's concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on 18Dec2020 at 12 PM for COVID-19 immunization (intramuscular in right arm) and experienced flushed and hot feeling. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. The vaccine was administered in a hospital facility.  On 08Jan2021 (12:30 PM), the patient experienced flushed or hot feeling 30 minutes after the second dose, followed by numb back of tongue or throat (best described like swallowing a good amount of throat numbing spray) that lasted about 2 hours. No treatment was administered for the events. The patient had not been tested for COVID-19 post-vaccination. The patient recovered from the events on 08Jan2021 (14:30).
Nausea, vomiting, hives around injection site. Temperature of 102.4. Malaise, dizziness. Started post injection. Sought medical attention. Mediated with Keflex, 500 mg,and  Benadryl.
pt recv vax & 2 days post vax pt exp a rash all over body;ER or MD visit was required;no tx given;sx cont as of 16DEC96;
This is a spontaneous report received from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 10May2021 at 14:30 (at the age of 49-years-old) as a single dose for COVID-19 immunization. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medication were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. On 17May2021, first dose after one week, patient experienced one swollen lymph nodes on right side of the armpit. It got better after 5-6days. she also had minor dizziness and weakness after one week of the shot. No therapeutic measures were taken as a result of reported events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events minor dizziness after one week of the shot, weakness after one week of the shot and first dose after one week, there is one swollen lymph nodes on right side of the armpit were resolving at the time of this report. No follow-up attempts are possible; No further information expected.